BUPRENORPHINE-NALOXONE J Code: J0572

Drug & Product Overview

HCPCS Descriptor Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine

HCPCS Added Date January 1, 2015

Manufacturer Multiple Manufacturers

Route of Administration Buccal, Sublingual

Generic Status Multi-Source; Generic

Dosage Form Film | Film, Soluble | Tablet | Tablet, Orally Disintegrating

About BUPRENORPHINE-NALOXONE

Buprenorphine-naloxone is a medication aligned to the HCPCS J Code: J0572 for billing, pricing, and reimbursement purposes in the United States. Classified under Opioid Analgesic, it is administered via the buccal or sublingual routes and manufactured by multiple companies.

Manufacturers, reach out to us to add more information.

NDC Code Information

14 NDC packages are crosswalked to J0572. Package detail is available to logged-in subscribers.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
•••••-••••-•• Log in to view	BUPRENORPHINE-NALOXONE
	BUPRENORPHINE-NALOXONE
	BUPRENORPHINE-NALOXONE
	BUPRENORPHINE-NALOXONE

Login to view 14 NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

BUPRENORPHINE-NALOXONE Pricing & Reimbursement

J0572 Private Payer Reimbursement

$4.33 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

BUPRENORPHINE-NALOXONE Medically Unlikely Edits (MUE)

The most billing units of J0572 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 3 mg.

Practitioner Office & Hospital Outpatient

0 units / day

Not payable in this setting

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

Not on the CMS JW / JZ list

CMS does not include Buprenorphine-naloxone (J0572) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J0572. Wastage billing guide →

BUPRENORPHINE-NALOXONE Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Opioid Dependence Opioid dependence opioid dependence

Drug Class

Opioid Antagonist [EPC]Opioid Antagonists [MoA]Partial Opioid Agonist [EPC]Partial Opioid Agonists [MoA]

Frequently Asked Questions

Is there an available Buprenorphine-Naloxone billing and coding guide?

We have not yet identified a manufacturer source of Buprenorphine-Naloxone billing and coding information.

Are there any available Buprenorphine-Naloxone patient assistance programs?

BUPRENORPHINE-NALOXONE patient assistance information can be found through Multiple Manufacturers. Visit Here →

Where can I find Buprenorphine-Naloxone prescribing information?

BUPRENORPHINE-NALOXONE prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date. Visit Here →

Where can I find Buprenorphine-Naloxone side effect information?

Our team has not yet identified a source of side effects information for BUPRENORPHINE-NALOXONE. Please check back in a few weeks.

Does billing BUPRENORPHINE-NALOXONE require JZ/JW wastage modifiers?

CMS does not include BUPRENORPHINE-NALOXONE (J0572) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J0572. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.